bf/NASDAQ:COYA_icon.jpeg

NASDAQ:COYA

Coya Therapeutics, Inc.

  • Stock

USD

Last Close

5.90

30/08 20:00

Market Cap

102.29M

Beta: -

Volume Today

4.79K

Avg: 49.57K

PE Ratio

−4.94

PFCF: −5.88

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.15
-
cash conversion cycle
-14.96K
-
cash per share
0.66
-
2.29
248.53%
3.21
40.13%
company equity multiplier
1.05
-
1.32
24.80%
-1.00
176.05%
1.16
215.76%
days of inventory outstanding
days of payables outstanding
15.42K
-
days of sales outstanding
456.08
-
dividend yield
ebit per revenue
-1.23
-
ebt per ebit
1.00
-
1.25
24.25%
0.99
20.92%
effective tax rate
0.00
-
-0.20
4,624.34%
-0.10
49.85%
enterprise value multiple
-5.30
-
-1.97
62.77%
-5.82
195.07%
fixed asset turnover
91.01
-
free cash flow per share
-0.61
-
-2.79
356.81%
-1.10
60.61%
gross profit margin
1.00
-
interest coverage
-4.03
-
inventory turnover
long term debt to capitalization
2.84
-
net income per ebt
1.00
-
1.20
20.40%
1.10
8.26%
net profit margin
-1.33
-
operating cash flow per share
-0.59
-
-2.79
372.82%
-1.10
60.61%
operating cycle
456.08
-
operating profit margin
-1.23
-
payables turnover
0.02
-
pretax profit margin
-1.21
-
price fair value
8.28
-
-1.46
117.66%
2.11
244.50%
receivables turnover
0.80
-
return on assets
-1.02
-
-1.75
72.02%
-0.19
88.93%
return on capital employed
-1.34
-
-2.15
60.56%
-0.20
90.53%
return on equity
-1.34
-
1.75
230.83%
-0.22
112.81%
total debt to capitalization
2.84
-
0.02
99.30%

All numbers in USD (except ratios and percentages)